Navigation Links
Patients at high risk of recurrences of heart disease: Breakthrough in prevention
Date:5/20/2010

This press release is available in French.

Montreal, May 20, 2010 The results of a major clinical study carried out at the Montreal Heart Institute (MHI) by Dr. Jean-Claude Tardif are now available in the journal Circulation Cardiovascular Imaging. Dr. Tardif is a cardiologist and director of the MHI Research Centre, as well as a professor in the faculty of medicine and holder of the atherosclerosis research chair at the Universit de Montral.

The promising findings of this study on VIA-2291 a medication developed by Via Pharmaceuticals, a San Francisco-based biotechnology firm relate to its capacity to effectively reduce inflammation, which can contribute to the formation and progression of atherosclerosis plaque and infarct.

"Up to now, standard treatments for patients with acute coronary syndrome (unstable angina and infarct) have not specifically reduced inflammation, an important component of atherosclerosis. However, research in recent years has allowed us to determine that the presence of inflammation significantly increases the risk of recurrence among these patients. The clinical study was conducted with about 200 patients, and the findings we're publishing show that VIA-2291 may finally offer the solution we need to target and reduce inflammation. In fact, these newly published data strongly support the evaluation of VIA-2291 in larger outcome trials," said Dr. Tardif.

The Montreal Heart Institute's Research Centre directed the study in several hospitals in Canada and the United States as well as analyzed all of the data, including data collected by CAT scans of coronary arteries.

"The publication of this new study attests once again to the excellence of the entire team at the Montreal Heart Institute's Research Centre. While we're clearly satisfied with the findings obtained with VIA-2291, we're even more thrilled at the prospect of taking a big step toward more effective and personalized prevention of cardiovascular disease," concluded Dr. Tardif.


'/>"/>

Contact: Rachel Ladouceur-Girard
rachel.ladouceur-girard@icm-mhi.org
514-376-3330, x 2641
University of Montreal
Source:Eurekalert

Related medicine news :

1. When Heart Patients Discharge Themselves, Hospital Bills Increase
2. A useful tool to detect in vivo angiogenesis in IBD patients: Narrow-band imaging
3. Older patients offer insight into the future of cystic fibrosis
4. Depressed chronic kidney disease patients more likely to face complications
5. First study examines postpolypectomy bleeding in colonoscopy patients on uninterrupted clopidogrel
6. POP ROCK BAND Honor Society Drummer Advocates for Inflammatory Bowel Disease Patients on Capitol Hill in Conjunction with World IBD Day
7. Older Patients More Apt to Be Happy With Plastic Surgery
8. Oncolytic viruses mediating anti-tumor immunity in human cancer patients
9. What Doctors Won't Tell Their Patients About Cancer
10. Well-tolerated radiotherapy provides longer life to patients with recurrent brain cancer
11. Challenging the use of routine repeated chest X-rays in certain patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... , ... July 27, 2017 , ... Team Novo Nordisk, ... Brand to the men’s pro squad as a stagiaire for the remainder of the ... professional debut on July 31st at the Tour of Utah. , “Every season we ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: Ashley ... major advancement in drug therapy for patients living with relapsing and primary multiple ... novel B cell targeted therapy that has been proven to significantly reduce signs ...
(Date:7/26/2017)... ... 26, 2017 , ... “We are dentists and we thought there could be ... “so we invented the MAGNETIC/ LOCK BRACKETS.” , The patent-pending MAGNETIC/ LOCK BRACKETS provides ... so, it offers an effective alternative to traditional braces. As a result, it enhances ...
(Date:7/26/2017)... Baton Rouge, Louisiana (PRWEB) , ... July 26, 2017 , ... ... their doctors to offer the ability for patients to schedule an appointment online in ... LocalMed directly from the Six Month Smiles provider directory will bring more Six Month ...
(Date:7/26/2017)... ... ... M. Musielak, a partner at the Andrew Cores Family Law Group, a division ... earlier this year. She will serve the membership in this capacity for a term of ... the organization’s by-laws. , Musielak joined the Andrew Cores Family Law Group ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... July 14, 2017 Endo International plc (NASDAQ: ... August 8, 2017.  Members of its senior management team will host ... at 8:30 a.m. ET. The dial-in number to ... International (678) 509-7598, and the passcode is 45397076. Please dial in ... A replay of the call will be ...
(Date:7/13/2017)... York City-based market research firm Kalorama Information notes seven trends ... new products to new costs, to the threat of generic ... Potential Pipeline Disruptors . Among them are ... Age-Driven Growth - True Impact Moment Arriving   ... growing population and, to a more extreme extent, the aging ...
(Date:7/11/2017)...  Bayer has awarded grants totaling more than $2 million ... prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians and ... and Uniformed Services University of the Health Sciences in ... recipients were announced last night during a reception at the ... Berlin, Germany . ...
Breaking Medicine Technology: